Radiopaedia Helpers

Spacing

error

"presence of H3.3 mutation either by H3-3A/H3-3B analysis or by p.Lys.36Met (K36M) expression"

Line 17:89 · 'p.L' should have one space.

"On immunohistochemistry diffuse nuclear expression of p.Lys36Met (K36M), an antibody against H3.3B is characteristic ¹."

Line 56:65 · 'p.L' should have one space.

"Chondroblastomas are characterised by a p.Lys36Met substitution on the H3-3B (H3F3B) or less frequently H3-3A (H3F3A) genes ¹."

Line 58:44 · 'p.L' should have one space.

Strong List Colon Position

error

"T1: intermediate signal"

Line 89:8 · When enboldening an intro, the colon should not be bold. 'T1: intermediate'

"T2: variable, heterogeneous intermediate signal intensity"

Line 90:8 · When enboldening an intro, the colon should not be bold. 'T2: variable'

"STIR: high signal"

Line 91:8 · When enboldening an intro, the colon should not be bold. 'STIR: high'

"T1 C+ (Gd): heterogeneous moderate enhancement together with enhancement of surrounding bone and soft-tissue oedema"

Line 92:8 · When enboldening an intro, the colon should not be bold. 'T1 C+ (Gd): heterogeneous'

Acronyms

warning

"Chondroblastoma accounts for one of the 'C's in the popular mnemonic for lucent bone lesions FEGNOMASHIC."

Line 2:100 · 'FEGNOMASHIC' has no definition. Spell it out if it's unfamiliar to the audience.

"On CT and MRI, the lesion can be categorised as Bone-RADS 4 unless histology has already been obtained ¹⁰."

Line 118:57 · 'RADS' has no definition. Spell it out if it's unfamiliar to the audience.

Emphasis

warning

"presence of H3.3 mutation either by H3-3A/H3-3B analysis or by p.Lys.36Met (K36M) expression"

Line 17:44 · Italics should be used only in exceptional circumstances: 'H3-3A/H3-3B '

"Chondroblastomas are characterised by a p.Lys36Met substitution on the H3-3B (H3F3B) or less frequently H3-3A (H3F3A) genes ¹."

Line 58:75 · Italics should be used only in exceptional circumstances: 'H3-3B (H3F3B) or less frequently H3-3A (H3F3A'

Number Formatting

warning

"presence of H3.3 mutation either by H3-3A/H3-3B analysis or by p.Lys.36Met (K36M) expression"

Line 17:94 · Check the number format against the style guide: '.36'.

Headings Valid

warning

Expected headings

H1 Terminology
H1 Usage
H1 Epidemiology
H2 Risk factors
H2 Associations
H1 Clinical presentation
H2 Complications
H1 Diagnosis
H2 Diagnostic criteria
H2 Diagnostic clues
H1 Pathology
H2 Aetiology
H2 Location
H2 Classification
H2 Macroscopic appearance
H2 Microscopic appearance
H2 Immunophenotype
H2 Markers
H2 Genetics
H1 Radiographic features
H2 Plain radiograph
H2 Mammography
H2 Antenatal ultrasound
H2 Transoesophageal echocardiography
H2 Ultrasound
H2 CT
H3 Dual-energy CT
H2 Angiography (DSA)
H2 MRI
H2 CT/MRI
H2 Nuclear medicine
H3 PET-CT
H3 PET-MRI
H1 Radiology report
H1 Treatment and prognosis
H2 Complications
H1 History and etymology
H1 Differential diagnosis
H2 Clinical differential diagnosis
H1 Practical points
H1 See also

"Signal characteristics"

Line 87:1 · "Signal characteristics" is not a recognised heading for this article type.

"Bone scintigraphy"

Line 95:1 · "Bone scintigraphy" is not a recognised heading for this article type.

Oxford Comma

suggestion

"Most chondroblastomas occur in the subchondral epiphyseal region of long bones such as the proximal or distal femur, the proximal tibia and the proximal humerus ^1-3. They can also occur in the talus, calcaneus, patella and pelvic bones e.g. the acetabulum and less frequently affect the ribs the spine or small bones of hands and feet ¹ or the craniofacial skeleton ^2,3. They are usually confined to a single bone."

Line 34:225 · Use the Oxford comma in 'calcaneus, patella and pelvic'.

Links

lucentlytic-bone-lesion-differential-diagnosis-mnemonic-2